Resources

This report presents the results of demonstration projects and other activities undertaken in Albania as part of a partnership between project Optimize (a collaboration between the World Health Organization and PATH) and the Albanian Institute of Public Health. The partnership aimed to demonstrate innovations, such as an online immunization registry and remote alarm system in the cold chain, that can help meet the demands of an increasingly large and costly portfolio of vaccines.

The Op.ti.mize e-newsletter was a quarterly publication that highlighted advances and innovations in health care logistics, technologies, and policy. Developed by project Optimize, a collaboration between PATH and the World Health Organization, this newsletter provided an overview of Optimize’s activities and areas of focus.

PATH is an innovator, researcher, implementation catalyst, and influential advocate on the global and country levels. This document highlights PATH's experience and expertise in translating data, knowledge, and messages to stimulate action by decision-makers in support of health innovations, policies, and sustainable resources.

This document presents a set of requirements that translate the needs of maternal health practitioners into the language of software and systems engineering. The document can inform software development for health systems worldwide and maternal health in particular. Find out more about PATH's work in digital health solutions.

This article, published in the New England Journal of Medicine (NEJM), reports results from a pivotal, large-scale Phase 3 trial of RTS,S/AS01 malaria vaccine. When compared to immunization with a control vaccine, infants (aged 6 to 12 weeks at first vaccination) vaccinated with RTS,S had one-third fewer episodes of both clinical and severe malaria and had similar reactions to the injection. In this trial, RTS,S demonstrated an acceptable safety and tolerability profile. The abstract of this article is available through the NEJM by clicking on "Visit web page" below, or for free access to the full lenth article please visit malariavaccine.org and click on "Read the NEJM article."